Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-29 4:57 pm | N/A N/A | Revolution Medicines Inc. | RVMD | Wei Lin Chief Medical Officer | 0 | $0 | 338,800 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 5:00 pm | N/A 2033-06-13 | 2seventy bio Inc. | TSVT | Wei Lin Director | 12,650 | $0 | 29,250 (Direct) | View |
| 2023-03-07 Option Award | 2023-03-09 9:48 pm | N/A 2033-03-07 | 2seventy bio Inc. | TSVT | Wei Lin Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-01 Other | 2023-02-03 08:53 am | N/A N/A | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 2 | $3.893 | 877,562 (Direct) | View |
| 2023-02-01 Other | 2023-02-03 08:53 am | N/A N/A | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 1,748 | $4.097 | 877,562 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 08:53 am | N/A 2033-01-31 | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 560,000 | $0 | 877,562 (Direct) | View |
| 2022-02-01 Other | 2022-02-03 7:54 pm | N/A N/A | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 1,562 | $11.6 | 587,724 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:54 pm | N/A 2032-01-31 | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 272,100 | $0 | 587,724 (Direct) | View |
Ownership | 2021-07-15 9:37 pm | N/A N/A | Erasca Inc. | ERAS | Wei Lin Chief Medical Officer | 0 | $0 | 1,145,833 (Direct) | View |